AliveCor Inc.

alivecor.com

AliveCor, Inc. is pioneering the creation of FDA-cleared machine learning techniques to enable proactive heart care and is recognized around the world for transforming cardiac care. The FDA-cleared KardiaMobile is the most clinically validated mobile EKG solution on the market. It is recommended by leading cardiologists and used by people worldwide for accurate EKG recordings. KardiaMobile, and KardiaBand, when paired with the Kardia app provide instant analysis for detecting atrial fibrillation (AF) and normal sinus rhythm in an EKG. Kardia is the first A.I. enabled platform to help clinicians manage patients for the early detection of atrial fibrillation, the most common cardiac arrhythmia and one that leads to a five times greater risk of stroke. KardiaBand is the first FDA-cleared medical device accessory for Apple Watch. AliveCor is recognized by FastCompany as 2018's No. 1 most innovative company in artificial intelligence. AliveCor is a privately-held venture backed company headquartered in Mountain View, Calif.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

DON'T CUT BACK ON ASTHMA MEDS DURING PANDEMIC, EXPERT ADVISES

Drugs | April 19, 2020

news image

Despite increased demand for inhalers in some parts of the United States, Americans with asthma shouldn't ration their medications during the coronavirus pandemic, the American Lung Association says. Rescue inhalers are in short supply in some areas because hospitals are giving albuterol to COVID-19 patients with severe symptoms to help them breathe, the group explained. Albuterol is a quick-relief medication used to treat shortness of breath and wheezing in people with asthma and some other...

Read More

Business Insights

LTS TAKES NEXT STEP IN ITS GROWTH JOURNEY WITH THE ACQUISITION OF TAPEMARK INC.

LTS Lohmann Therapie-Systeme AG | August 23, 2022

news image

LTS LOHMANN Therapie-Systeme AG announces the closing of the acquisition of Tapemark Inc. located in St. Paul, MN, USA. This acquisition combines Tapemark, a world-class CDMO specialized in transdermal drug delivery systems and oral thin films as well as unit dose semi-solid drug and iontophoresis products with LTS, a leading pharmaceutical technology company that develops and manufactures innovative drug delivery systems such as Transdermal Patches Oral Thin Films and Micro Array Patches (MAP) ...

Read More

Pharmacy Market

LILLY COLLABORATES WITH SAMSUNG TO BOOST COVID-19 ANTIBODY MANUFACTURING AMID SUPPLY CONCERNS

Lilly | November 18, 2020

news image

Seven days after Eli Lilly won a FDA crisis approval for its COVID-19 counter acting agent, worries over restricted supplies are as of now springing up, and the organization is getting an accomplished assembling accomplice to help with the worldwide scale-up. Under a drawn out arrangement with Samsung Biologics, the organizations are set to "incredibly quicken the worldwide gracefully" for Lilly's COVID-19 antibodies, Samsung Biologics said in a delivery. Lilly would...

Read More

Research

ROIVANT GROWS COMPUTATIONAL DRUG DISCOVERY ENGINE WITH ACQUISITION OF SILICON THERAPEUTICS

Roivant Sciences | March 01, 2021

news image

Silicon Therapeutics has assembled an exclusive industry-driving computational physics platform for the in silico design and optimization of small molecule drugs for testing disease targets. The platform incorporates custom strategies dependent on quantum mechanics, sub-atomic elements and measurable thermodynamics to beat basic bottlenecks in drug disclosure projects, for example, anticipating restricting energies and conformational conduct of molecules. Silicon Therapeutics'...

Read More
news image

DON'T CUT BACK ON ASTHMA MEDS DURING PANDEMIC, EXPERT ADVISES

Drugs | April 19, 2020

Despite increased demand for inhalers in some parts of the United States, Americans with asthma shouldn't ration their medications during the coronavirus pandemic, the American Lung Association says. Rescue inhalers are in short supply in some areas because hospitals are giving albuterol to COVID-19 patients with severe symptoms to help them breathe, the group explained. Albuterol is a quick-relief medication used to treat shortness of breath and wheezing in people with asthma and some other...

Read More
news image

Business Insights

LTS TAKES NEXT STEP IN ITS GROWTH JOURNEY WITH THE ACQUISITION OF TAPEMARK INC.

LTS Lohmann Therapie-Systeme AG | August 23, 2022

LTS LOHMANN Therapie-Systeme AG announces the closing of the acquisition of Tapemark Inc. located in St. Paul, MN, USA. This acquisition combines Tapemark, a world-class CDMO specialized in transdermal drug delivery systems and oral thin films as well as unit dose semi-solid drug and iontophoresis products with LTS, a leading pharmaceutical technology company that develops and manufactures innovative drug delivery systems such as Transdermal Patches Oral Thin Films and Micro Array Patches (MAP) ...

Read More
news image

Pharmacy Market

LILLY COLLABORATES WITH SAMSUNG TO BOOST COVID-19 ANTIBODY MANUFACTURING AMID SUPPLY CONCERNS

Lilly | November 18, 2020

Seven days after Eli Lilly won a FDA crisis approval for its COVID-19 counter acting agent, worries over restricted supplies are as of now springing up, and the organization is getting an accomplished assembling accomplice to help with the worldwide scale-up. Under a drawn out arrangement with Samsung Biologics, the organizations are set to "incredibly quicken the worldwide gracefully" for Lilly's COVID-19 antibodies, Samsung Biologics said in a delivery. Lilly would...

Read More
news image

Research

ROIVANT GROWS COMPUTATIONAL DRUG DISCOVERY ENGINE WITH ACQUISITION OF SILICON THERAPEUTICS

Roivant Sciences | March 01, 2021

Silicon Therapeutics has assembled an exclusive industry-driving computational physics platform for the in silico design and optimization of small molecule drugs for testing disease targets. The platform incorporates custom strategies dependent on quantum mechanics, sub-atomic elements and measurable thermodynamics to beat basic bottlenecks in drug disclosure projects, for example, anticipating restricting energies and conformational conduct of molecules. Silicon Therapeutics'...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us